A clinical research of efficacy of botulotoxin A medicines (BTX-A) application in the orthopedic treatment of spastic feet deformities was carried out. It was defined that injections of BTX-A medicines in the case of dynamic feet deformities (Dysport) caused lowering of spasticity by Ashworth scale, increasing in range of movement in ankle joint, improvement in biomechanical abilities of the foot. But in the case of fixed feet deformities the results were less positive. So, BTX-A medicines are effective in orthopedic management of spastic feet deformities before they are fixed.
